Conestoga Capital Advisors, LLC Bio Techne Corp Transaction History

Conestoga Capital Advisors, LLC

$6.58 Billion
Q2 2024

A detailed history of Conestoga Capital Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 311,037 shares of TECH stock, worth $23.2 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

311,037

Previous 264,247 17.71%

Holding current value

$23.2 Million

Previous $18.6 Million 19.81%

% of portfolio

0.34%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$62.12 - $84.15 $2.91 Million - $3.94 Million	46,790 Added 17.71%	311,037 $22.3 Million
Q1 2024 Apr 26, 2024	BUY	$65.98 - $77.09 $864,008 - $1.01 Million	13,095 Added 5.21%	264,247 $18.6 Million
Q4 2023 Jan 26, 2024	SELL	$52.83 - $78.22 $180,678 - $267,512	-3,420 Reduced 1.34%	251,152 $19.4 Million
Q3 2023 Oct 27, 2023	BUY	$67.52 - $89.42 $4,388 - $5,812	65 Added 0.03%	254,572 $17.3 Million
Q2 2023 Jul 28, 2023	SELL	$73.76 - $85.98 $335,460 - $391,037	-4,548 Reduced 1.76%	254,507 $20.8 Million
Q1 2023 Apr 21, 2023	SELL	$71.62 - $86.62 $22,918 - $27,718	-320 Reduced 0.12%	259,055 $19.2 Million
Q4 2022 Jan 31, 2023	BUY	$80.67 - $352.29 $15.6 Million - $68.3 Million	193,860 Added 295.9%	259,375 $21.5 Million
Q3 2022 Oct 24, 2022	BUY	$282.54 - $391.85 $309,663 - $429,467	1,096 Added 1.7%	65,515 $18.6 Million
Q2 2022 Jul 22, 2022	SELL	$322.67 - $449.65 $129,068 - $179,860	-400 Reduced 0.62%	64,419 $22.3 Million
Q1 2022 Apr 25, 2022	BUY	$353.85 - $487.79 $26,538 - $36,584	75 Added 0.12%	64,819 $28.1 Million
Q4 2021 Jan 21, 2022	SELL	$456.15 - $525.06 $4.76 Million - $5.48 Million	-10,445 Reduced 13.89%	64,744 $33.5 Million
Q3 2021 Oct 22, 2021	BUY	$444.87 - $538.88 $376,360 - $455,892	846 Added 1.14%	75,189 $36.4 Million
Q2 2021 Jul 27, 2021	BUY	$387.35 - $450.26 $2.39 Million - $2.78 Million	6,175 Added 9.06%	74,343 $33.5 Million
Q1 2021 Apr 23, 2021	SELL	$314.62 - $411.0 $54 Million - $70.5 Million	-171,589 Reduced 71.57%	68,168 $26 Million
Q4 2020 Jan 26, 2021	SELL	$246.9 - $321.87 $35.9 Million - $46.8 Million	-145,294 Reduced 37.73%	239,757 $76.1 Million
Q3 2020 Oct 23, 2020	BUY	$232.22 - $282.96 $5.1 Million - $6.21 Million	21,947 Added 6.04%	385,051 $95.4 Million
Q2 2020 Aug 03, 2020	BUY	$185.43 - $279.56 $2.22 Million - $3.35 Million	11,976 Added 3.41%	363,104 $95.9 Million
Q1 2020 Apr 17, 2020	BUY	$161.17 - $221.51 $4.75 Million - $6.53 Million	29,496 Added 9.17%	351,128 $66.6 Million
Q4 2019 Jan 24, 2020	SELL	$189.68 - $222.09 $638,652 - $747,777	-3,367 Reduced 1.04%	321,632 $70.6 Million
Q3 2019 Oct 25, 2019	SELL	$183.56 - $216.72 $658,062 - $776,941	-3,585 Reduced 1.09%	324,999 $63.6 Million
Q2 2019 Aug 02, 2019	BUY	$188.72 - $215.43 $1.37 Million - $1.56 Million	7,256 Added 2.26%	328,584 $68.5 Million
Q1 2019 Apr 18, 2019	BUY	$136.09 - $200.44 $279,120 - $411,102	2,051 Added 0.64%	321,328 $63.8 Million
Q4 2018 Jan 28, 2019	BUY	$132.75 - $203.8 $1.33 Million - $2.04 Million	9,995 Added 3.23%	319,277 $46.2 Million
Q3 2018 Oct 25, 2018	BUY	$147.44 - $204.11 $5.44 Million - $7.53 Million	36,915 Added 13.55%	309,282 $63.1 Million
Q2 2018 Jul 20, 2018	BUY	$144.9 - $165.58 $1.68 Million - $1.92 Million	11,595 Added 4.45%	272,367 $40.3 Million
Q1 2018 Apr 24, 2018	SELL	$131.46 - $151.04 $1.85 Million - $2.12 Million	-14,050 Reduced 5.11%	260,772 $39.4 Million
Q4 2017 Jan 22, 2018	BUY	$121.17 - $134.75 $3.42 Million - $3.81 Million	28,240 Added 11.45%	274,822 $35.6 Million
Q3 2017 Oct 20, 2017	BUY	$113.59 - $123.78 $28 Million - $30.5 Million	246,582	246,582 $29.8 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.93B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Account

Conestoga Capital Advisors, LLC Bio Techne Corp Transaction History